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ABSTRACT
The objective of this study was to assess the effect 
of a selective antibiotic treatment strategy based on 
a quick bacteriological on-farm test (Petrifilm, 3M 
Corp., St. Paul, MN) compared with the conventional 
antibiotic treatment of all cows having clinical endome-
tritis (CE) defined by the presence of purulent vaginal 
discharge on both clinical cure rate and reproductive 
performance. The study was simultaneously conducted 
with dairy cows reared under a highly supplemented ro-
tational grazing system in Argentina and in a freestall 
system in Slovakia. Cows having an abnormal vaginal 
discharge (VD, indicative of clinical endometritis) on 
21 to 35 d in milk (DIM) were randomly allocated to 
1 of 2 study groups: selective treatment (ST) or con-
ventional treatment (CT). All cows in the CT group (n 
= 174) received a single intrauterine administration of 
500 mg of cephapirin. In the ST group (n = 178), treat-
ment decision was made according to the results of the 
bacteriological on-farm test. For this test, we collected 
intrauterine samples with the cytobrush technique and 
stroke the brushes onto 2 different Petrifilm plates, one 
for aerobic count and another for Enterobacteriaceae 
count, incubated the plates, and counted the number 
of colonies after 24 h. Positive cows (≥5 colonies in 
one or both plates) received a single intrauterine treat-
ment with 500 mg of cephapirin, whereas negative cows 
(<5 colonies) remained untreated. Clinical cure rate 
was assessed by direct vaginal inspection at 14 d after 
treatment (VD-0). The odds for conception at first 
artificial insemination, artificial insemination by 80 
DIM, pregnancy by 100 DIM, and for nonpregnancy by 
200 DIM were estimated with mixed logistic regression 
models. The hazard of conception was also assessed 
with proportional hazard regression model. The selec-
tive antibiotic treatment strategy based on the outcome 
of Petrifilm test reduced the number of required treat-
ments (57%) and maintained similar efficacy in terms 
of clinical cure and reproductive performance as the 
conventional antibiotic treatment of all endometritic 
cows.
Key words: clinical endometritis, purulent vaginal 
discharge, bacteria, antibiotic treatment, Petrifilm
INTRODUCTION
Clinical endometritis (CE) is commonly defined as 
an endometrial inflammation with the presence of pu-
rulent or mucopurulent vaginal discharge (VD) with-
out systemic signs of illness in cows with more than 20 
DIM (Sheldon et al., 2006). Some cows with abnormal 
VD have no cytological evidence of endometritis, and 
therefore the term “purulent vaginal discharge” (PVD) 
can be used instead of CE (Denis-Robichaud and Du-
buc, 2015b; Dubuc et al., 2010). Clinical endometritis 
or PVD affects 15 to 20% of cows at 4 to 6 wk post-
partum and impairs fertility, consequently worsening 
the economic situation of farms (LeBlanc, 2008). Be-
side prevention strategies, treatment of CE is a topic 
of controversial discussion (Dubuc et al., 2011). This 
controversy is triggered by high self-cure rates rang-
ing from 63 to 77% (Gautam et al., 2010; Dubuc et 
al., 2011; Plöntzke et al., 2011; Giuliodori et al., 2013) 
and by the unsatisfactory results of some treatment 
regimens. For example, the use of proteolytic enzymes 
is not recommended (Drillich et al., 2005), homeopathic 
remedies were not effective (Arlt et al., 2009), and lo-
cal treatment with dextrose yielded inconsistent results 
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(Brick et al., 2012; Machado et al., 2015; Maquivar et 
al., 2015). In addition, conflicting reports exist on the 
use of prostaglandin F2α with regard to cure rate and 
reproductive performance (Mejía and Lacau-Mengido, 
2005; Hirsbrunner et al., 2006; Kaufmann et al., 2010; 
Dubuc et al., 2011; Haimerl et al., 2013). However, 
the efficacy of an intrauterine antibiotic therapy with 
cephapirin has been demonstrated in several studies 
(LeBlanc et al., 2002; Runciman et al., 2009; Denis-
Robichaud and Dubuc, 2015a). Cephapirin, a first-
generation cephalosporin, is approved for the treatment 
of bovine endometritis in many countries, but not in 
the United States. In general, the use of antibiotics 
in food-producing animals, particularly highly critical 
important antibiotics (“reserve antibiotic”) in human 
medicine (e.g., third- and fourth-generation cephalo-
sporins), should be kept to a minimum. In this sense, 
for example, the European Union is funding programs 
to assess the amount of antibiotics used and their resis-
tance rates (directive 2003/99/EC). In Latin America, 
the first regulations have recently been released in 
Argentina (directives 834/2015 and 391/2015) with 
the intent of assessing antibiotic usage and bacterial 
resistance in food-producing animals. Because the use 
of antimicrobials in food animals is considered to lead 
to the development of resistance to these drugs (San-
tos et al., 2010; Kasimanickam et al., 2016), an urgent 
need exists for new treatment strategies (e.g., selected 
treatment strategies). Detailed clinical examination, 
the assessment of animal-based welfare parameters, 
and the use of predictive laboratory tests have been 
suggested as relevant measures to improve the situa-
tion on farm (Trevisi et al., 2014). Thus, the challenge 
for practitioners is how they can reduce the amount of 
antibiotics to a minimum by implementing a preventive 
management program at the herd level to control the 
proportion of cows with CE and then to treat them 
efficaciously to maintain their fertility.
Petrifilm (3M Corp., St. Paul, MN) was originally de-
veloped for on-site determination of bacteria in drinking 
water, food products, and other items (Bredie and de 
Boer, 1992; Schraft and Watterworth, 2005). Recently, 
the use of Petrifilm as a rapid on-farm test for detection 
of mastitis pathogens in dairy cows was shown to en-
able implementation of a selected and targeted mastitis 
treatment strategy (McCarron et al., 2009; Cameron et 
al., 2014). Therefore, our hypothesis was that the use of 
this rapid on-farm bacteriological test could help us to 
select cows with PVD for antibiotic treatment and thus 
reduce the number antibiotic treatments in dairy cows. 
Our objective was to assess the effect of a strategy that 
is based on the use of the on-farm test followed by 
selected treatment of positively identified cows (selec-
tive antibiotic treatment) compared with conventional 
treatment of all cows with PVD on both clinical cure 
rate and reproductive performance.
MATERIALS AND METHODS
Study Design
This study was simultaneously conducted on dairy 
farms in Argentina and Slovakia as a completely ran-
domized block design with country as the blocking 
criterion and cow as the experimental unit. Sample size 
was estimated with a confidence level of 95% and a 
power of 80%. We assumed cure rates of 50% and 65% 
for selective and conventional groups, respectively. The 
estimated sample size was 133 cases per group or ap-
proximately 266 cows to be enrolled in the trial. A one-
sided significance level was used because no negative 
effect of treatment was expected. This estimation was 
run with the option Sample size/Estimate differences 
between percentages in WinEpi (http://www.winepi.
net/uk/index.htm). Cows included were postpartum 
dairy cows (21–35 DIM) having VD ≥1 (abnormal 
vaginal discharges) and not having cesarean section, 
fetotomy, or systemic antibiotic treatment after partu-
rition (to avoid false-negative bacteriological findings). 
From a total of 352 enrolled cows, 152 belonged to the 
Argentinean farm (78 primiparous and 74 multiparous 
cows) and 200 to the Slovakian farm (all multiparous 
cows).
Study Farms and Herd Management
The Argentinian part of the study was conducted on 
a commercial dairy farm with 2,600 Holstein Friesian 
cows, located in Carlos Casares (35°37′ S, 61°22′ W), 
between November 2013 and August 2015. The land 
base of the dairy farms was 2,000 ha. Prepartum transi-
tion cows that were within 4 wk of expected calving 
date were maintained on dry lots, fed a low DCAD diet, 
and monitored for signs of calving by farm employees 
trained to assist parturition. After calving, cows were 
sent for 3 d to the fresh herd and kept on a dry lot. 
Lactating cows were at pasture in a rotational system 
(different paddock in the morning and afternoon). Feed 
was composed of mixed pastures (lucerne, tall fescue) 
and winter annual grasses (ryegrass) and supplemented 
with TMR diets (corn silage, soybean pellets, and corn 
meal) formulated to meet or exceed the NRC (2001) 
nutrient requirements for lactating Holstein cows 
weighing 650 kg and producing 45 kg of milk (3.5% 
fat). Concentrates (40% soybean pellets and 60% corn 
meal) were offered twice daily during milking. Average 
milk yield was 9,600 kg per lactation. Calving occurred 
year round except for the hot summer months (January 
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and February). Farm veterinarians visited the farms 
routinely every second week for reproductive examina-
tion. After a voluntary waiting period of 50 d, cows 
were detected for estrus twice daily and artificially 
inseminated with the a.m.–p.m. rule. Estrus detection 
was facilitated by tail painting. Cows were considered 
in estrus when over 50% of tail paint was removed. 
Ovsynch protocol was used for cows not bred within 70 
DIM. Pregnancy was diagnosed by ultrasound between 
30 and 45 d post insemination. Pregnant cows were 
rechecked by ultrasound at 150 d of gestation. Relevant 
data were managed with herd management software 
Protambo Master 3.0 (DIRSA SA, Buenos Aires, Ar-
gentina).
The European part of the study was conducted on 
a commercial dairy farm with 2,600 Holstein Friesian 
cows in the region of Záhorie, Slovakia, between August 
2013 and February 2015. Cows were housed in freestall 
facilities with cubicles and concrete floors. Feeding was 
based on a TMR consisting of wheat straw, corn silage, 
lucerne silage, beet pulp silage, concentrates, soybean 
meal, and corn grain as the main components. Cows 
were milked 3 times daily and the herd average milk 
yield was 9,000 kg per lactation. Before parturition 
cows were brought to a straw-bedded group calving 
pen. Calving occurred all year round. The voluntary 
waiting period was set at 50 DIM. Cows were bred by 
AI after observed estrus. Ovsynch protocol was used 
for cows not bred within 70 DIM. Pregnancy diagnosis 
was performed after 35 d post insemination by manual 
transrectal palpation and ultrasonography of the uterus 
and its contents by local veterinarians. Pregnant cows 
were rechecked by transrectal palpation at 150 d of 
gestation. Relevant data were managed with herd man-
agement software DairyComp 305 (Valley Agricultural 
Software, Tulare, Canada).
Clinical Examination and Sampling
All dairy cows were examined between 21 to 35 DIM 
by manual vaginal inspection with a gloved hand (Plet-
icha et al., 2009) and transrectal palpation. Vaginal 
discharge was assessed with the following score: VD-0 
(normal clear discharge), VD-1 (clear discharge with 
pus flecks), VD-2 (mucopurulent not fetid discharge), 
and VD-3 (watery, purulent or brown-colored, and 
fetid). The BCS of cows was assessed on a 5-point scale 
(Edmonson et al., 1989), and cows were tail bled to de-
termine BHB concentration in whole blood (FreeStyle 
Precision; Abbott Germany, Wiesbaden, Germany). 
After clinical examination, intrauterine samples were 
collected using the cytobrush technique as described 
earlier (Kasimanickam et al., 2004; Prunner et al., 
2014). The cytobrush (Gynobrush, Heinz Herenz, 
Hamburg, Germany; 20 mm in length and 7 mm in 
diameter), screwed on a metal rod and protected by 
a disposable plastic catheter and a plastic sheath, was 
inserted into the uterine cavity similar to AI technique. 
Inside the uterine cavity, the sheath was drawn back 
and the brush was moved forward and rolled onto the 
endometrial wall. We sampled every cow twice to ob-
tain one specimen for bacteriological testing and the 
second for cytological examination. The first brush was 
washed out in 3 mL of lysogenic broth medium, and 
1 mL of the fluid was subsequently placed in each of 
the 2 different Petrifilm plates, one for aerobic count 
and another for Enterobacteriaceae count (3M Corp.), 
which were then incubated at 37°C. The Petrifilm plates 
were inspected after 24 h of incubation, and the num-
ber of grown colonies was counted. From 88 randomly 
selected animals, a routine bacteriological analysis was 
performed to obtain information about the population 
of present bacteria (Westermann et al., 2010). The sec-
ond cytobrush was used to determine the proportion of 
PMNL in the endometrial sample. A total of 200 cells 
were counted under a microscope by 400× magnifica-
tion to determine the proportion of PMNL (Melcher et 
al., 2014). A proportion of 5% PMNL was chosen as the 
threshold for endometritis (endometrial inflammation). 
These findings were used to determine the proportion 
of false-positive findings for endometritis by vaginal 
examination (VD-1 to VD-3) in both groups (Wester-
mann et al., 2010).
Animal Treatment
Cows with even ear tag numbers were allocated to 
the selective treatment (ST) group and cows having 
odd ear tag numbers were allocated to the conventional 
treatment (CT) group. Animals in the ST group were 
treated according to the readout on the Petrifilm plates 
after 24 h of incubation. Each sample was categorized 
as positive if ≥5 colonies were counted on one or both 
plates. Positive cows received a single intrauterine 
treatment with 500 mg of cephapirin (Metricure, In-
tervet, Boxmeer, the Netherlands) according to the 
manufacturer’s instructions, whereas negative cows (<5 
colonies on one or both plates) remained untreated. 
All cows in the CT group received a single intrauterine 
administration of 500 mg of cephapirin, independent of 
the results of the cytobrush (Figure 1). Authors or the 
farm veterinarians applied the intrauterine treatments. 
Clinical cure was assessed by manual vaginal inspec-
tion at 14 d after treatment by the authors or by the 
farm veterinarians. Clinical cure was defined as VD-0. 
Reproductive performance was assessed by the odds for 
conception at first artificial insemination (CR1AI), 
artificial insemination by 80 DIM (AI80), pregnancy 
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by 100 DIM (P100), and nonpregnancy by 200 DIM 
(NP200) and also by the hazard of conception.
Data Management and Statistical Methods
Results from clinical examinations were recorded 
on case report forms and transferred into spreadsheet 
software (Excel 2010, Microsoft Office Corporation, 
Redmond, WA). The statistical analyses were per-
formed with SAS (version 9.2; SAS Institute Inc., Cary, 
NC). Animal data included parity, date of parturition, 
BCS, BHB concentration, VD, results from cytologi-
cal and bacteriological examination, and reproductive 
performance. Mixed logistic regression models were 
used to assess the effect of treatment strategy on clini-
cal cure rate, CR1AI, AI80, P100, and NP200. These 
logistic models included the random effect of farm and 
the fixed effect of parity (1 vs. ≥2), VD at enrollment 
(1 vs. 2 vs. 3), treatment strategy (CT vs. ST), and 
second-order interactions. Models were also controlled 
for the fixed effect of cytological examination (<5% 
vs. ≥5% PMNL), daily milk production (every 5 kg), 
BCS (every 0.25 unit), and BHB (every 0.1 mmol/L) 
as continuous predictors. Modeling was performed by 
backward removal of predictors with a P > 0.1 (except 
for the effect of treatment that was forced to remain in 
models). The Cox proportional hazard regression mod-
els included the same fixed effects as the logistic mod-
els and the effect of country under the strata option. 
Modeling was also performed as previously described 
Figure 1. Flowchart showing study design and treatment allocation. VD 1–3 = vaginal discharge with a score of 1 to 3. Petrifilm (3M Corp., 
St. Paul, MN).
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for logistic regression. Time intervals (median ± 95% 
CI) and survival function estimates were obtained from 
Kaplan–Meier survival analysis.
RESULTS
Overall, 352 cows were enrolled into this study, 178 
allocated to the ST group (Argentina, 78 cows; Slo-
vakia, 100 cows) and the remaining 174 to CT group 
(Argentina, 74 cows; Slovakia, 100 cows; Figure 1). In 
the ST group, 57% of cows had a negative Petrifilm test 
result, so this strategy allowed a 57% reduction in the 
number of antibiotic treatments required.
Cure Rate and Reproductive Performance
Effects of treatment strategy on cure rate and re-
productive performance are shown in Table 1. The 
percentage of cows cured in the Argentinean herd was 
42.3% and in the Slovakian herd 57.6%. Group (ST 
vs. CT) had not effect on the odds for cure [adjusted 
odds ratio (AOR) = 0.939, P = 0.800] given that the 
proportion of cured cows was 58 versus 60% for ST and 
CT, respectively. Primiparous cows tended to have a 
higher cure rate than multiparous herd mates (71 vs. 
55%, P = 0.069). The odds for cure decreased with VD 
(P < 0.001) given that the proportion of cured cows 
was 80% (87/109) vs. 60% (89/148) vs. 33% (30/92) 
for VD-1, VD-2, and VD-3, respectively. The odds 
for cure were 0.392 (95% CI: 0.210–0.733) and 0.122 
(95% CI: 0.060–0.251) for cows with VD-2 and VD-
3, respectively. The odds for cure increased by 28.8% 
for every increase of 5 kg/d in daily milk production 
above the mean of 35.36 kg/d (AOR = 1.288, 95% CI: 
1.079–1.537, P = 0.005).
In the Argentinean herd, CR1AI was 28.8%, and in 
the Slovakian herd it was 21.3%. Group (ST vs. CT) 
had no effect on the odds for CR1AI (AOR = 1.117, P = 
0.555) given that the proportion of cows that conceived 
was 25 versus 24% for ST and CT, respectively. Group 
had no effect on the odds for AI80 (46 vs. 50%, AOR = 
0.913, P = 0.664) or on the odds for P100 (32 vs. 30%, 
AOR = 1.142, P = 0.603). Also, no effect was observed 
on the odds for NP200 (AOR = 1.113, P = 0.724) given 
that the proportion of open cows was 21 versus 19% 
for ST and CT cows, respectively. Multiparous cows 
tended to have lower odds for CR1AI than primiparous 
cows (22 vs. 33%, AOR = 0.583, 95% CI: 0.319–1.067, 
P = 0.080). Multiparous cows had lower odds for P100 
than primiparous (29 vs. 38%, AOR = 0.495, 95% CI: 
Table 1. Clinical cure rate and reproductive performance of cows with purulent vaginal discharge in a selective antimicrobial treatment strategy 
compared with conventional treatment strategy
Group % No./total AOR1 95% CI P-value
Clinical cure rate2    
 Conventional3 60.34 105/174 1    
 Selective4 57.87 103/178 0.939 0.576–1.531 0.800
Conception at first AI  
 Conventional3 24.07 39/162 1    
 Selective4 24.68 39/158 1.171 0.692–1.984 0.555
AI by 80 DIM  
 Conventional3 49.38 80/162 1    
 Selective4 45.57 72/158 0.913 0.571–1.460 0.664
Pregnancy by 100 DIM  
 Conventional3 29.75 47/158 1    
 Selective4 32.03 49/153 1.142 0.692–1.884 0.603
Nonpregnancy by 200 DIM  
 Conventional3 18.98 26/137 1    
 Selective4 20.97 26/124 1.113 0.615–2.014 0.724
 
Median 95% CI AHR5 95% CI P-value
Calving to first AI    
 Conventional3 80.5 78–82 1    
 Selective4 81.0 80–82 1.056 0.840–1.329 0.638
Calving to conception    
 Conventional3 114.5 105–125 1    
 Selective4 107.0 98–129 0.984 0.745–1.300 0.909
1AOR = adjusted odds ratio.
2Cure was declared when cows had a clear normal vaginal discharge (VD-0) at the recheck 14 d later.
3Conventional treatment strategy: all cows received 500 mg of cephapirin (intrauterine; Metricure, Intervet, the Netherlands).
4Selective treatment strategy: cows with ≥5 colonies after 24 h of incubation in any of the 2 Petrifilm (3M Corp., St. Paul, MN) plates received 
500 mg of cephapirin (intrauterine), whereas those with <5 colonies remained untreated.
5AHR = adjusted hazard ratio.
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0.247–0.991, P = 0.047). The odds for P100 tended to 
increase by 3.3% for every increase of 5 kg/d in daily 
milk production above the mean of 35.36 kg/d (AOR = 
1.033, 95% CI: 0.996–1.072, P = 0.078). The odds for 
AI80 decreased by 10.6% for every increase of 0.1 mM 
of BHB above the mean of 0.65 mM (AOR = 0.894, 
95% CI: 0.823–0.971, P = 0.008). Finally, the odds for 
NP200 tended to increase 4.7% for every increase of 
0.1 mM of BHB above the mean of 0.65 mM (AOR = 
1.047, 95% CI: 0.991–1.106, P = 0.100). The remaining 
predictors had no effect on the odds for any of the 
evaluated response variables (P > 0.1).
Treatment strategy group (ST vs. CT) had no effect 
on the hazard of AI [adjusted hazard ratio (AHR) = 
1.056, P = 0.638]. The median interval from calving to 
first AI was 81 vs. 80.5 d for ST and CT, respectively. 
Also, group had no effect on the hazard of conception 
(AHR = 0.984, P = 0.909). The median calving to 
conception interval was 114.5 vs. 107 d for ST and CT, 
respectively. Finally, multiparous cows had a lower 
hazard of conception than primiparous ones (AHR = 
0.608, P = 0.022) and took 15 d longer to get pregnant 
(117 vs. 102 d, respectively). The remaining predictors 
had no effect on the hazards of both insemination and 
conception (P > 0.1).
Cytological and Bacteriological Examination
According to cytological evaluation, the overall 
proportion of cows with PVD having no evidence of 
uterine inflammation (false-positive cows to CE) was 
8.8% (31/352). The distribution of these false-positive 
cows were 10.3 and 7.3% for CT and ST, respectively 
(χ2 = 1.081, df = 1, P = 0.298).
In total, 43% of cows in the ST group had positive 
Petrifilm test results and received an intrauterine an-
timicrobial treatment. The outcome of the Petrifilm 
test was not related to VD (P = 0.349) given that the 
percentage of positive cows to Petrifilm was 46.9, 46.3, 
and 40.4% for those having VD-1, VD-2, and VD-3, 
respectively. In addition, the outcome of the Petrifilm 
test was not associated with cytological examination 
(P = 0.949); the percentage of positive cows based on 
the Petrifilm test was 44.9 and 45.2% for those having 
positive (≥5% PMNL) and negative cytology (<5% 
PMNL), respectively.
From a subsample of 88 cows, samples were not only 
tested by Petrifilm but also in the laboratory. For these 
cows, the odds for Trueperella pyogenes increased with 
VD (P = 0.001), given that the odds were 1.339 (95% 
CI: 0.405–4.426) and 8.928 (95% CI: 2.521–31.615) for 
cows having VD-2 and VD-3, respectively. The per-
centage of cows with T. pyogenes was 31.8% (7/22), 
38.5% (10/26), and 81.0% (25/31) for cows having 
VD-1, VD-2, and VD-3, respectively. The presence of 
T. pyogenes reduced the odds for cure (AOR = 0.354, 
95% CI: 0.133–0.942, P = 0.038) given that cured cows 
were 52% (22/44) vs. 76% (28/37) for cows with versus 
without T. pyogenes, respectively.
DISCUSSION
Cure Rate and Reproductive Performance
The main hypothesis tested in this study was that 
the use of the rapid on-farm bacteriological test could 
help us to select cows with PVD for antibiotic treat-
ment and thus reduce the number of required antibi-
otic treatments. In agreement with our hypothesis, ST 
based on the outcome of the Petrifilm test reduced the 
number of required treatments by approximately 60% 
with a similar efficacy as CT, in which all cows received 
an antibiotic therapy, in terms of clinical cure and 
reproductive performance. To the best of our knowl-
edge, this study is the first to document this concept. 
Furthermore, this finding was observed in 2 completely 
different farming systems, a highly supplemented graz-
ing system (in Argentina) and a freestall system (in 
Slovakia).
Studies on the on-farm use of Petrifilm to make 
selective antimicrobial treatment decisions in mastitis 
therapy have recently found no differences between 
Petrifilm-based ST and CT in the odds for quarter-
level cure, new intramammary infection, and clinical 
mastitis (Cameron et al., 2014). They also found no 
effect in the odds for bacteriological cure and treat-
ment failure and the hazard of clinical cure and culling 
(Lago et al., 2011a,b). Therefore, the on-farm use of 
Petrifilm has allowed 21% (Cameron et al., 2014) and 
50% (Lago et al., 2011a) reductions in the number of 
required antibiotic treatments without affecting the 
intended therapeutic outcome. Although these works 
dealt with mastitis, a completely different disease than 
CE, the results are in line with ours. Petrifilm-based 
ST strategy permitted a notable reduction in the use of 
antibiotics, while still obtaining the same clinical cure 
and reproductive performance of cows. This finding is 
relevant because antibiotic use in animal production is 
blamed for increasing bacterial resistance to antibiotics 
in humans.
It should be noted that this study was not designed 
to assess the self-cure rate of cows with CE or to test 
the efficacy of a treatment with cephapirin. The imple-
mentation of a protocol for selective treatment requires 
adequate management prerequisites, such as trained 
personnel, in combination with other routines for which 
cows need to be restrained. Furthermore, herd-specific 
economic consideration should be made. Testing all 
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cows and reducing the amount of antibiotics can be 
assumed to be economically superior for herds with a 
low incidence of bacteriological endometritis compared 
with herds in which almost all endometritic cows should 
be treated.
Cytological and Bacteriological Examination
Surprisingly, the outcome of Petrifilm test (i.e., num-
ber of colonies in one or both plates) was related to 
neither VD nor cytological examination. Unfortunately, 
we do not have an explanation for this finding. Some 
studies have demonstrated that cows with abnormal 
VD may have neither PMNL nor bacteria sampled from 
the endometrium (Dubuc et al., 2010; Westermann et 
al., 2010; Hartmann et al., 2016). In the current study, 
8.8% of cows with abnormal VD were negative to cy-
tology (false-positive cows). This figure is a bit lower 
than previously reported (Westermann et al., 2010). 
However, evaluation of inflammatory cells by cytobrush 
technique and manual inspection of VD could reflect 
different uterine conditions as proposed by Dubuc et 
al. (2010). Consequently, the lack of agreement between 
the 2 techniques could play a role in confounding the 
relationship among Petrifilm, VD, and PMNL count.
A general agreement exists that nonspecific bacterial 
contamination at parturition could lead to the estab-
lishment of uterine infections (Williams et al., 2005). 
However, severe endometrial lesions are commonly 
associated with the presence of T. pyogenes, which is 
the most prevalent bacteria in the late postpartum pe-
riod (Westermann et al., 2010). It is recognized as an 
important pathogen associated with CE, probably due 
to synergistic action with anaerobic bacteria (Williams 
et al., 2005). Our findings that the odds for clinical 
cure decreased with both VD score and the presence 
of T. pyogenes, and in turn, that the odds for isolat-
ing T. pyogenes increased with the VD score and with 
endometrial PMNL, could be interpreted as being in 
line with a recent study showing a high prevalence of 
cytological endometritis in infected cows (Bicalho et 
al., 2016). The finding also agrees with other research 
showing that concurrent and subsequent infection of T. 
pyogenes with gram-negative anaerobes such as Fuso-
bacterium necrophorum and Prevotella melaninogenica 
is associated with higher odds for CE and with reduced 
odds for pregnancy (Bonnett et al., 1991; Williams et 
al., 2005).
CONCLUSIONS
A treatment strategy based on the use of a quick 
on-farm bacteriological test (Petrifilm) to select cows 
with PVD for antibiotic treatment reduced the required 
number of treatments without decreasing clinical cure 
or reproductive performance of dairy cows compared 
with the conventional treatment of all cows having 
PVD. Thus, Petrifilm is a valuable tool to assist in 
the prudent use of antimicrobials in the global dairy 
production system.
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